Isek 10 Softgel Capsule contains isotretinoin 10 mg, a retinoid derivative primarily indicated for the treatment of severe recalcitrant nodular acne that is unresponsive to conventional therapies such as antibiotics and topical agents. Isotretinoin acts by reducing sebaceous gland size and sebum production, inhibiting the proliferation of Propionibacterium acnes, and exerting anti-inflammatory effects, thereby addressing multiple pathogenic factors in acne development. The capsule formulation ensures precise dosing and improved bioavailability. Isek 10 is prescribed under strict medical supervision due to its potent teratogenicity and potential adverse effects, including mucocutaneous dryness, elevated liver enzymes, hyperlipidemia, and possible mood alterations. Baseline and periodic monitoring of liver function tests, lipid profile, and pregnancy status in females of childbearing potential are mandatory during treatment. Patients must adhere to contraceptive measures to prevent pregnancy during therapy and for at least one month after discontinuation. The recommended dosage is individualized based on clinical response and patient tolerance, typically administered once or twice daily with food to enhance absorption. Isek 10 Softgel Capsule should be used cautiously in patients with hepatic or renal impairment, and contraindicated in pregnancy and hypersensitivity to isotretinoin or any excipients. Proper patient education and adherence to guidelines are essential to optimize therapeutic outcomes and minimize risks.